Evidence map›Paper›PMID 34945268›Full record

ReviewJournal of clinical medicine2021

Imaging in Transcatheter Mitral Valve Replacement: State-of-Art Review.

Manuel Barreiro-Perez, Berenice Caneiro-Queija, Luis Puga, Rocío Gonzalez-Ferreiro, Robert Alarcon, Jose Antonio Parada, Andrés Iñiguez-Romo, Rodrigo Estevez-Loureiro

Open access · goldAbstract readReview
In one paragraph

Review in Journal of clinical medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
2.8field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Contemporary Transcatheter Approaches to Mitral Regurgitation.Reviews in cardiovascular medicine · 2026
    Review
  3. Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Transcatheter mitral valve replacement: there is still work to be done.European heart journal supplements : journal of the European Society of Cardiology · 2022
    Article
  9. Review
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Manuel Barreiro-PerezCardiology Department, University Hospital Alvaro Cunqueiro, Galicia Sur Health Research Institute (IISGS), 36213 Vigo, Pontevedra, Spain.ORCID 0000-0001-7489-2935
Berenice Caneiro-QueijaCardiology Department, University Hospital Alvaro Cunqueiro, Galicia Sur Health Research Institute (IISGS), 36213 Vigo, Pontevedra, Spain.
Luis PugaCardiology Department, University Hospital Alvaro Cunqueiro, Galicia Sur Health Research Institute (IISGS), 36213 Vigo, Pontevedra, Spain.ORCID 0000-0002-6173-3449
Rocío Gonzalez-FerreiroCardiology Department, University Hospital Alvaro Cunqueiro, Galicia Sur Health Research Institute (IISGS), 36213 Vigo, Pontevedra, Spain.
Robert AlarconCardiology Department, University Hospital Alvaro Cunqueiro, Galicia Sur Health Research Institute (IISGS), 36213 Vigo, Pontevedra, Spain.ORCID 0000-0003-2389-4812
Jose Antonio ParadaCardiology Department, University Hospital Alvaro Cunqueiro, Galicia Sur Health Research Institute (IISGS), 36213 Vigo, Pontevedra, Spain.
Andrés Iñiguez-RomoCardiology Department, University Hospital Alvaro Cunqueiro, Galicia Sur Health Research Institute (IISGS), 36213 Vigo, Pontevedra, Spain.
Rodrigo Estevez-LoureiroCardiology Department, University Hospital Alvaro Cunqueiro, Galicia Sur Health Research Institute (IISGS), 36213 Vigo, Pontevedra, Spain.
University Hospital Complex Of Vigo · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Mitral regurgitation is the second-most frequent valvular heart disease in Europe and it is associated with high morbidity and mortality. Recognition of MR should encourage the assessment of its etiology, severity, and mechanism in order to determine the best therapeutic approach. Mitral valve surgery constitutes the first-line therapy; however, transcatheter procedures have emerged as an alternative option to treat inoperable and high-risk surgical patients. In patients with suitable anatomy, the transcatheter edge-to-edge mitral leaflet repair is the most frequently applied procedure. In non-reparable patients, transcatheter mitral valve replacement (TMVR) has appeared as a promising intervention. Thus, currently TMVR represents a new treatment option for inoperable or high-risk patients with degenerated or failed bioprosthetic valves (valve-in-valve); failed repairs, (valve-in-ring); inoperable or high-risk patients with native mitral valve anatomy, or those with severe annular calcifications, or valve-in-mitral annular calcification. The patient selection requires multimodality imaging pre-procedural planning to select the best approach and device, study the anatomical landing zone and assess the risk of left ventricular outflow tract obstruction. In the present review, we aimed to highlight the main considerations for TMVR planning from an imaging perspective; before, during, and after TMVR.

Indexed as

cardiac computed tomographymitral regurgitationstructural heart interventiontranscatheter mitral valve replacementtransoesophageal echocardiography

Identifiers

PMID34945268
PMCPMC8706772
OpenAlexW4200020409

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.